# OnCo record circulate-japan (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/circulate-japan/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "circulate-japan" ;
  schema:name "CIRCULATE-Japan (GALAXY / VEGA / ALTAIR)"@en ;
  schema:alternateName "GALAXY"@en, "VEGA"@en, "ALTAIR"@en ;
  schema:description "Japan's national programme tests whether a blood test after surgery should decide who gets chemotherapy, and whether treating a positive test early helps."@en ;
  schema:url <https://onco.cc/trials/circulate-japan/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.nature.com/articles/s41591-022-02115-4>, <https://doi.org/10.1038/s41591-026-04428-0> ;
  onco:status "active" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:drugs <https://onco.cc/drugs/signatera/>, <https://onco.cc/drugs/trifluridine-tipiracil/>, <https://onco.cc/drugs/capox/> ;
  onco:institutions <https://onco.cc/institutions/ncc-japan/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/> ;
  onco:trials <https://onco.cc/trials/dynamic/>, <https://onco.cc/trials/altair/>, <https://onco.cc/trials/dynamic-iii/> ;
  onco:people <https://onco.cc/people/jeanne-tie/>, <https://onco.cc/people/yoshino-takayuki/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-henriksen-ctdna-stage-iii-colorectal-improve-it-ccr-2022/>, <https://onco.cc/key-papers/paper-nakamura-triumph-ctdna-pertuzumab-trastuzumab-her2-colorectal-nat-med-2021/> .